Terns Pharmaceuticals, Inc. (TERN)
49.61
+1.17
(+2.42%)
USD |
NASDAQ |
Mar 23, 16:00
49.70
+0.09
(+0.18%)
After-Hours: 07:55
Terns Pharmaceuticals Total Assets (Quarterly) : 301.65M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 937.61M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| ADMA Biologics, Inc. | 633.35M |
| Arcellx, Inc. | 603.99M |
| Corcept Therapeutics, Inc. | 838.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.58M |
| Shareholders Equity (Quarterly) | 284.07M |
| Debt to Equity Ratio | 0.0036 |
| Current Ratio | 19.52 |
| Net Debt Paydown Yield | -0.02% |